Australia’s leading contract research organization focused on medicinal cannabis treatments
200 women to take part to monitor the safety & efficacy of medical cannabis as a management option for refractory chronic pain, a common endometriosis symptom.
SYDNEY, NSW, AUSTRALIA, January 31, 2021 /EINPresswire.com/ Applied Cannabis Research is pleased to announce Aruma Labs (Aruma) has joined Australia’s longest running observational study of medicinal cannabis products, the CA Clinics Observational Study (CACOS ), with a focus on collecting data from patients with endometriosis.
Endometriosis is a notoriously painful condition affecting more than 11% of Australian women, according to Endometriosis Australia. It is characterised by the presence of endometrial tissue, normally found inside the uterus, in other areas of the abdomen. The reduction in quality of life for women with endometriosis has been estimated at A$4 billion per annum (Ernst & Young (2019): The Cost of Endometrio